Koichi Amano Selected Research

Koichi Amano Research Topics

Disease

51	Rheumatoid Arthritis 04/2022 - 12/2002
16	Vasculitis (Vasculitides) 08/2022 - 11/2015
13	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2021 - 09/2015
8	Infections 02/2022 - 12/2002
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2022 - 01/2007
6	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 06/2020 - 01/2012
5	Glomerulonephritis 08/2022 - 03/2019
5	Microscopic Polyangiitis 01/2021 - 11/2016
4	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2021 - 01/2021
3	Inflammation (Inflammations) 01/2021 - 11/2016
3	Fever (Fevers) 10/2019 - 09/2005
3	Neoplasms (Cancer) 07/2018 - 12/2002
3	Lupus Nephritis 01/2013 - 01/2007
2	Osteonecrosis (Kienbock's Disease) 01/2022 - 01/2009
2	Hemorrhage 01/2021 - 01/2021
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021 - 09/2005
2	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 10/2019
2	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 12/2019 - 10/2017
2	Adult-Onset Still's Disease 03/2018 - 03/2012
2	Congenital Abnormalities (Deformity) 12/2015 - 07/2007
2	Opportunistic Infections (Opportunistic Infection) 07/2013 - 12/2002
1	Herpes Zoster 04/2022
1	Type IV Ehlers-Danlos Syndrome 01/2022
1	Aneurysm (Aneurysms) 01/2022
1	Blood Vessel Dissection 01/2022
1	Thrombosis (Thrombus) 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 01/2021
1	Nephrosclerosis 01/2021
1	Giant Cell Arteritis (Horton Disease) 01/2021
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2020
1	Necrosis 01/2020
1	Systemic Vasculitis 03/2018
1	Lymphoma (Lymphomas) 01/2018
1	Epstein-Barr Virus Infections 01/2018
1	Liver Diseases (Liver Disease) 01/2017
1	Hodgkin Disease (Hodgkin's Disease) 01/2017
1	Jaundice (Icterus) 01/2017
1	Vascular Diseases (Vascular Disease) 10/2015
1	Acute Disease 01/2014
1	Pneumocystis Infections 07/2013
1	Latent Tuberculosis 07/2013
1	Hypersensitivity (Allergy) 07/2013

Drug/Important Bio-Agent (IBA)

21	tocilizumab (atlizumab)FDA Link 05/2020 - 01/2009
17	Methotrexate (Mexate)FDA LinkGeneric 02/2022 - 12/2004
15	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 09/2016
9	Biological ProductsIBA 05/2022 - 01/2009
9	Infliximab (Remicade)FDA Link 01/2020 - 01/2005
8	Abatacept (Orencia)FDA Link 01/2021 - 09/2014
8	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2017 - 12/2002
7	GlucocorticoidsIBA 01/2021 - 01/2007
7	Tumor Necrosis Factor InhibitorsIBA 01/2016 - 04/2012
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 09/2005
4	GLPG0634IBA 04/2022 - 01/2022
4	Prednisolone (Predate)FDA LinkGeneric 01/2021 - 09/2005
4	Rituximab (Mabthera)FDA Link 01/2021 - 12/2017
4	Monoclonal AntibodiesIBA 01/2020 - 01/2009
4	Etanercept (Enbrel)FDA Link 10/2015 - 12/2002
3	Peroxidase (Myeloperoxidase)IBA 08/2022 - 09/2017
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2012
3	Antirheumatic Agents (DMARD)IBA 12/2020 - 01/2006
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 01/2007
3	Interleukin-6 (Interleukin 6)IBA 01/2014 - 01/2009
3	Tacrolimus (Prograf)FDA LinkGeneric 01/2013 - 02/2009
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2012 - 01/2009
2	Adalimumab (Humira)FDA Link 02/2022 - 06/2012
2	SteroidsIBA 01/2022 - 12/2002
2	C-Reactive ProteinIBA 01/2021 - 10/2019
2	tofacitinibIBA 01/2021 - 01/2017
2	CytokinesIBA 10/2015 - 06/2003
2	mizoribineIBA 11/2014 - 01/2013
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2007 - 09/2005
2	bucillamine (SA 96)IBA 01/2006 - 01/2005
1	omega-Chloroacetophenone (Mace)IBA 04/2022
1	Collagen Type III (Type III Collagen)IBA 01/2022
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2021
1	IntegrinsIBA 01/2021
1	CreatinineIBA 01/2021
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2021
1	EpitopesIBA 01/2021
1	VaccinesIBA 01/2021
1	ChAdOx1 nCoV-19IBA 01/2021
1	BNT162 VaccineIBA 01/2021
1	InterferonsIBA 01/2020
1	sifalimumabIBA 01/2020
1	InterleukinsIBA 01/2020
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 10/2019
1	baricitinibIBA 07/2018
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 03/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2018
1	CollagenIBA 10/2015
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 05/2014
1	AntigensIBA 07/2013

Therapy/Procedure

17	Therapeutics 01/2021 - 06/2003
8	Remission Induction 01/2021 - 11/2016
2	Drug Therapy (Chemotherapy) 03/2018 - 01/2017
1	Retreatment 01/2014